Lilly a possible suitor for Novartis AG’s animal-health unit
Indianapolis-based Eli Lilly and Co., Bayer AG and Boehringer Ingelheim GmbH are among companies that may consider an offer if the Swiss drugmaker proceeds with the animal-health sale.
Indianapolis-based Eli Lilly and Co., Bayer AG and Boehringer Ingelheim GmbH are among companies that may consider an offer if the Swiss drugmaker proceeds with the animal-health sale.
U.S. lawmakers, influenced by companies including Indianapolis-based Eli Lilly and Co., Cisco Systems Inc. and Qualcomm Inc., are considering the second set of patent-law changes in three years as the courts try to race ahead of Congress.
Indiana officials don’t expect HealthCare.gov to be able to share individual account information with the state’s Medicaid computer systems until the end of the year.
Obamacare put an end to health insurers’ worst methods for avoiding risk. But that doesn’t mean insurers have ended their risk-shifting ways. Not at all.
State officials announced Thursday that they will extend Indiana’s high-risk insurance pool through the end of January to accommodate Hoosiers who have been unable to enroll in coverage through the federal marketplace.
Hoosiers’ poor health, combined with an aggressive health care system and an uncompetitive health insurance sector, means Hoosiers, in spite of the fact that they earn just 86 cents for every dollar earned by the average American, are spending nearly $1.13 on health care for every dollar spent by Americans.
So-called “zero-premium plans” are priced in such a way that their premiums would be no greater than the federal tax subsidies that low-income buyers could claim.
San Francisco-based Genstar Capital is exploring selling the 2,600-employee company in the wake of failing early this year to renegotiate the company’s massive debt load.
Why are Indiana’s hospitals cutting jobs. Because they’re spooked about cuts to Medicare payments. They should be.
Premiums written by the firm’s insurance subsidiaries hit $96.6 million, an increase of nearly 19 percent over the third quarter a year ago and 4 percent over the second quarter.
Today’s specialty medications are modern miracles, helping millions of patients with chronic, life-threatening illnesses such as cancer, multiple sclerosis and rheumatoid arthritis.
With a $60 million-plus investment, the university aims to take molecules from discovery to clinical trials.
Eli Lilly and Co. has been counting on torrid growth in China to help offset losses from patent expirations in other markets, but now slower growth in the Chinese economy and bribery allegations against Lilly and two other drugmakers have hampered Lilly’s growth there.
Obamacare’s exchanges are requiring working Americans to grasp minute details of their employers’ health plans in order to avoid a nasty surprise from the IRS.
Indiana companies are planning different methods to adapt to the health care landscape next year.
It’s long been known that Obamacare would make health benefits more expensive for most employers. Now, it’s finally becoming clearer by how much: about 9 percent, on average, according to a series of actuarial studies.
The heads of WellPoint Inc., Aetna Inc. and at least 10 other insurers met with the Obama administration Wednesday to discuss correcting flaws in how data from the U.S. health-care marketplaces is transferred to the companies.
The Indiana-based system that operates three hospitals in the Indianapolis area said it is trying to cut its expenses by as much as $500 million, or 20 percent.
A proposal calls for a medical education center that’s being developed by IU, the University of Evansville, the University of Southern Indiana and Ivy Tech Community College.
A consortium of Indiana University, Purdue University and University of Notre Dame can operate for another five years with the grant funds.